{
  "id": 13751758,
  "title": "MediaAlpha CEO Steven Yi sells $263,320 in company stock",
  "url": "https://urgent.news/2026/10/11/mediaalpha-ceo-steven-yi-sells-263-320-in-company-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-11T16:01:14.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/mediaalpha-ceo-steven-yi-sells-263320-in-company-stock-93CH-4942757"
  },
  "original_language": "en",
  "account": "Steven Yi, the CEO, President, and Co-Founder of MediaAlpha Inc., sold a total of $263,320 worth of company stock on October 8 and 9, 2026. The shares, representing Class A Common Stock, were sold at varying prices between $10.0393 and $11.0068 per share on October 8, and subsequently between $11.00 and $11.02 per share on October 9. The transactions adhered to a previously established Rule 10b5-1 trading plan, which aimed to address tax liabilities from the vesting of restricted stock units. As of the current price of $10.09, MediaAlpha's stock has declined 22% year-to-date, although analysts believe the company is undervalued. Post the sale, Yi remains a significant shareholder with 2,313,707 shares. MediaAlpha reported a second-quarter revenue of $317 million, surpassing analysts' expectations and marking a 26% YoY increase, driven by higher insurance carrier spending on the company's platform. This optimistic revenue growth was supported by Canaccord's price target increase to $17 from $15 and a maintained Buy rating. However, JPMorgan took a more neutral stance, setting a $15 price target. The article highlights MediaAlpha's financial performance and analyst opinions, providing a comprehensive view of the situation.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Rapport Therapeutics CEO Abraham Ceesay sells $143,272 in stock",
        "url": "https://urgent.news/2026/10/10/rapport-therapeutics-ceo-abraham-ceesay-sells-143-272-in-stock",
        "published": "2026-10-10T17:31:06.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}